Cryptococcosis laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) |
Sergekorjian (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Cryptococcosis}} | {{Cryptococcosis}} | ||
{{CMG}} {{AE}} {{SSK}}; {{YD}} | |||
==Overview== | ==Overview== |
Revision as of 16:09, 31 December 2015
Cryptococcosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cryptococcosis laboratory tests On the Web |
American Roentgen Ray Society Images of Cryptococcosis laboratory tests |
Risk calculators and risk factors for Cryptococcosis laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Serge Korjian M.D.; Yazan Daaboul, M.D.
Overview
Laboratory Findings
Detection of cryptococcal antigen (capsular material) by culture of CSF, sputum and urine provides definitive diagnosis.
Culture
- The gold standard for diagnosing cryptococcal infection; culture is traditionally identify Cryptococcus from human body samples.
- Blood cultures may be positive in heavy infections.
Microscopy
- India Ink can be performed on CSF to quickly visualize Cryptococcus cells under a microscope; however, it can have limited sensitivity.
- Histopathology for detection of narrow-based budding yeasts in tissue can also be used.
Antigen detection
- Antigen detection can be used on CSF or serum for detection of early, asymptomatic cryptococcal infection in HIV-infected patients.
- It has a higher sensitivity than microscopy or culture.
- Techniques used include:
- Latex agglutination (LA)
- Enzyme immunoassay (EIA)
- Lateral flow assay (LFA)